SPARC

SUN PHARMA ADVANCED RESEARCH COMPANY

Mid Cap BSE: 532872 NSE: SPARC
₹221.35
-2.2 (-0.98%)
As on 09 August, 2022 | 16:33

Sun Pharma Advanced Research Company Share Price

Sun Pharma Advanced Research Company Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Sun Pharma Advanced Research Company Share Returns

  • Over 1 Month 4.68%
  • Over 3 Month -8.1%
  • Over 6 Month -31.29%
  • Over 1 Year -22.42%

Sun Pharma Advanced Research Company Key Statistics

P/E Ratio -29.7
PEG Ratio -1.6
Market Cap Cr 6,018
Price to Book Ratio 1.1
EPS -7.5
Dividend 0
Relative Strength Index 54.75
Money Flow Index 52.8
MACD Signal 3.21
Average True Range 7.66

Sun Pharma Advanced Research Company Investment Rating

  • Master Rating:
  • Sun Pharma Advd.Resh. has an operating revenue of Rs. 143.72 Cr. on a trailing 12-month basis. An annual revenue de-growth of -44% needs improvement, Pre-tax margin of -148% needs improvement, ROE of -651% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sun Pharma Advanced Research Company Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 28
  • 25
  • 62
  • 28
  • 22
  • 28
  • Operating Expenses Qtr Cr
  • 107
  • 92
  • 73
  • 83
  • 76
  • 78
  • Operating Profit Qtr Cr
  • -78
  • -67
  • -11
  • -55
  • -54
  • -50
  • Depreciation Qtr Cr
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • Interest Qtr Cr
  • 2
  • 2
  • 2
  • 3
  • 5
  • 4
  • Tax Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Net Profit Qtr Cr
  • -82
  • -71
  • -16
  • -55
  • -61
  • -57

Sun Pharma Advanced Research Company Technicals

EMA & SMA

Current Price
221.35
-2.2 (-0.98%)
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • 219.51
  • 50 Day
  • 219.81
  • 100 Day
  • 231.57
  • 200 Day
  • 258.99
  • 20 Day
  • 219.95
  • 50 Day
  • 211.36
  • 100 Day
  • 236.01
  • 200 Day
  • 259.07

Sun Pharma Advanced Research Company Resistance and Support

PIVOT
₹224.52
Resistance
  • First Resistance
  • 227.04
  • Second Resistance
  • 230.52
  • Third Resistance
  • 233.04
Support
  • First Resistance
  • 221.04
  • Second Resistance
  • 218.52
  • Third Resistance
  • 215.04
  • RSI
  • 54.75
  • MFI
  • 52.8
  • MACD Single Line
  • 3.21
  • MACD
  • 3.2

Sun Pharma Advanced Research Company Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 178,457
  • 4,522,100
  • 25.34
  • Week
  • 336,584
  • 19,855,067
  • 58.99
  • 1 Month
  • 338,800
  • 11,061,819
  • 32.65
  • 6 Month
  • 495,499
  • 20,191,603
  • 40.75

Sun Pharma Advanced Research Company Result Highlights

Sun Pharma Advanced Research Company Synopsis

NSE-Medical-Biomed/Biotech

Sun Pharma Advanced is involved in the business activities of Research and experimental development on natural sciences and engineering. Company’s Total Operating Revenue is Rs. 252.96 Cr. and Equity Capital is Rs. 26.21 Cr. for the Year ended 31/03/2021. Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837.
  • Market Cap
  • 6,018
  • Sales
  • 144
  • Shares in Float
  • 8.43
  • No of funds
  • 67
  • Yield
  • Book Value
  • 192.48
  • U/D Vol ratio
  • 1.1
  • LTDebt / Equity
  • Alpha
  • -0.12
  • Beta
  • 1.59

Sun Pharma Advanced Research Company

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 69.09%
  • 69.09%
  • 68.1%
  • Mutual Funds
  • 0.24%
  • 0.24%
  • 0.02%
  • Foreign Portfolio Investors
  • 2.4%
  • 2.38%
  • 2.51%
  • Financial Institutions/ Banks
  • Individual Investors
  • 16.46%
  • 14.73%
  • 16.94%
  • Others
  • 11.81%
  • 13.56%
  • 12.43%

Sun Pharma Advanced Research Company Management

  • Name
  • Designation
  • Mr. Dilip S Shanghvi
  • Chairman
  • Dr. T Rajamannar
  • Non Executive Director
  • Dr. Robert J Spiegel
  • Non Executive Director
  • Mr. Sudhir V Valia
  • Non Executive Director
  • Ms. Bhavna Doshi
  • Independent Director
  • Dr. Ferzaan Engineer
  • Independent Director

Sun Pharma Advanced Research Company Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sun Pharma Advanced Research Company Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-08
  • Quarterly Results & Others
  • Inter alia, to consider and evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.
  • 2022-05-17
  • Audited Results
  • 2022-02-04
  • Quarterly Results
  • 2021-11-01
  • Quarterly Results
  • 2021-09-01
  • Others
  • inter alia, to consider and approve / evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.

Sun Pharma Advanced Research Company MF Shareholding

  • Name
  • Amount(cr)
  • Quant Small Cap Fund Growth
  • 1712
  • Motilal Oswal Nifty 500 Fund Regular Growth
  • 295
  • Nippon India Nifty Smallcap 250 Index Fund Reg Gr
  • 291
  • Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth
  • 248
  • Quant ESG Equity Fund Regular Growth
  • 78

Sun Pharma Advanced Research Company FAQs

What is Share Price of Sun Pharma Advanced Research Company ?

Sun Pharma Advanced Research Company share price is ₹221 As on 09 August, 2022 | 16:19

What is the Market Cap of Sun Pharma Advanced Research Company ?

The Market Cap of Sun Pharma Advanced Research Company is ₹6018 Cr As on 09 August, 2022 | 16:19

What is the P/E ratio of Sun Pharma Advanced Research Company ?

The P/E ratio of Sun Pharma Advanced Research Company is -26.8 As on 09 August, 2022 | 16:19

What is the PB ratio of Sun Pharma Advanced Research Company ?

The PB ratio of Sun Pharma Advanced Research Company is 192.7 As on 09 August, 2022 | 16:19

Q1FY23